FHIR IG Statistics: ValueSet/TreatmentScheduledDAMYDA
Resources that use this resource
No resources found
Resources that this resource uses
Narrative
Note: links and images are rebased to the (stated) source
This value set includes codes based on the following rules:
- Include these codes as defined in
https://kip.rkkp.dk/fhir/CodeSystem/ATC| Code | Display | Definition |
| L01AA01 | Cyklophosphamid | L01AA01 - cyclophosphamide |
| L01AA03 | Melfalan | L01AA03 - melphalan |
| L01AA09 | Bendamustin | L01AA09 - bendamustine |
| L01DB01 | Adriamycin (Doxorubicin) | L01DB01 - Doxorubicin |
| M05BA08 | Zolendronat (Zoledronsyre) | M05BA08 - zoledronic acid |
| M05BA03 | Pamidronat (Pamidronsyre) | M05BA03 - pamidronic acid |
| M05BX04 | Denosumab | M05BX04 - denosumab |
| L01FX08 | Elotuzumab | L01FX08 - elotuzumab |
| L01FC01 | Daratumumab | L01FC01 - daratumumab |
| L01FC02 | Isatuximab | L01FC02 - isatuximab |
| L01XH03 | Panobinostat | L01XH03 - panobinostat |
| L04AX02 | Thalidomid | L04AX02 - thalidomide |
| L04AX04 | Lenalidomid | L04AX04 - lenalidomide |
| L04AX06 | Pomalidomid | L04AX06 - pomalidomide |
| L01XG01 | Bortezomib | L01XG01 - bortezomib |
| L01XG02 | Carfilzomib | L01XG02 - carfilzomib |
| L01XG03 | Ixazomib | L01XG03 - ixazomib |
| H02 | Steroid (kun steroid, givet som palliation) | H02 - CORTICOSTEROIDS FOR SYSTEMIC USE |
- Include these codes as defined in
https://kip.rkkp.dk/fhir/CodeSystem/SKS| Code | Display | Definition |
| BWG | Strålebehandling | BWG - Strålebehandling |
| BWHA309 | Højdosis melfalan med stamcellestøtte | BWHA309 - Behandling med højdosis melfalan (konditionering) |
| BOQF1 | Allogen KMT | BOQF1 - Allogen knoglemarvstransplantation |
- Include these codes as defined in
https://kip.rkkp.dk/fhir/CodeSystem/GenericValues| Code | Display | Definition |
| other | Øvrig | Other - used to choose unspecific value not in a valueset |
Source
{
"resourceType": "ValueSet",
"id": "TreatmentScheduledDAMYDA",
"text": {
"status": "extensions",
"div": "<!-- snip (see above) -->"
},
"url": "https://kip.rkkp.dk/fhir/ValueSet/TreatmentScheduledDAMYDA",
"version": "2.12.0",
"name": "TreatmentScheduledDAMYDA",
"title": "Planlagt behandling (DAMYDA)",
"status": "active",
"experimental": true,
"date": "2022-07-08T00:00:00+02:00",
"publisher": "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S",
"contact": [
{
"name": "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S",
"telecom": [
{
"system": "url",
"value": "https://trifork.com"
},
{
"system": "email",
"value": "rbk@trifork.com"
}
]
}
],
"description": "Planlagt behandling (DAMYDA)",
"compose": {
"include": [
{
"system": "https://kip.rkkp.dk/fhir/CodeSystem/ATC",
"concept": [
{
"code": "L01AA01",
"display": "Cyklophosphamid"
},
{
"code": "L01AA03",
"display": "Melfalan"
},
{
"code": "L01AA09",
"display": "Bendamustin"
},
{
"code": "L01DB01",
"display": "Adriamycin (Doxorubicin)"
},
{
"code": "M05BA08",
"display": "Zolendronat (Zoledronsyre)"
},
{
"code": "M05BA03",
"display": "Pamidronat (Pamidronsyre)"
},
{
"code": "M05BX04",
"display": "Denosumab"
},
{
"code": "L01FX08",
"display": "Elotuzumab"
},
{
"code": "L01FC01",
"display": "Daratumumab"
},
{
"code": "L01FC02",
"display": "Isatuximab"
},
{
"code": "L01XH03",
"display": "Panobinostat"
},
{
"code": "L04AX02",
"display": "Thalidomid"
},
{
"code": "L04AX04",
"display": "Lenalidomid"
},
{
"code": "L04AX06",
"display": "Pomalidomid"
},
{
"code": "L01XG01",
"display": "Bortezomib"
},
{
"code": "L01XG02",
"display": "Carfilzomib"
},
{
"code": "L01XG03",
"display": "Ixazomib"
},
{
"code": "H02",
"display": "Steroid (kun steroid, givet som palliation)"
}
]
},
{
"system": "https://kip.rkkp.dk/fhir/CodeSystem/SKS",
"concept": [
{
"code": "BWG",
"display": "Strålebehandling"
},
{
"code": "BWHA309",
"display": "Højdosis melfalan med stamcellestøtte"
},
{
"code": "BOQF1",
"display": "Allogen KMT"
}
]
},
{
"system": "https://kip.rkkp.dk/fhir/CodeSystem/GenericValues",
"concept": [
{
"code": "other",
"display": "Øvrig"
}
]
}
]
}
}
FHIR